After eight years of changing treatment regimens to manage Stage 4 lung cancer, Bessie van Antwerp happily reports a major tumour shrinkage thanks to the targeted drug, osimertinib.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies
Dr Thobile Goba-Mjwara describes the diagnostic journey of lung cancer and how new treatments and biomarker tests are leading the way to hope.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies
 The Cancer Association of South Africa (CANSA) shares the most common questions that are asked regarding lung cancer.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies
Cancer affects one in four South Africans through diagnosis of family, friends, colleagues or self. In South Africa, lung cancer is the fifth most common cancer in women and the third most common cancer in men.1 Earlier detection of lung cancer is imperative to improve the survival rates of this disease.2
Oncology Buddies is proud to present the first Advanced NSCLC ALK+ lung cancer patient journey for your ease of reference and understanding of the route your journey may look like. Please note: this patient journey is only for ALK+ lung cancer and not applicable for all lung cancer patients.
Lung cancer is one of the most common cancers globally affecting 2,09 million people in 2018.1 Lung cancer is the most common cause of cancer death with 1,76 million deaths worldwide in 2018.1 Smoking and lung cancer People who smoke cigarettes are 15 to 30 times more likely to get lung cancer or die from lung cancer than people who do not smoke.2 The best way to reduce your risk of lung cancer is to not smoke and to avoid second hand smoke.3 Quitting smoking at any age can lower the risk of lung cancer.2 Signs and symptoms of lung…
